GE

276.29

+0.12%↑

RTX

151.9

-1.32%↓

CAT

417.84

-1.1%↓

BA

229.49

-0.58%↓

GEV.US

605.48

+0.89%↑

GE

276.29

+0.12%↑

RTX

151.9

-1.32%↓

CAT

417.84

-1.1%↓

BA

229.49

-0.58%↓

GEV.US

605.48

+0.89%↑

GE

276.29

+0.12%↑

RTX

151.9

-1.32%↓

CAT

417.84

-1.1%↓

BA

229.49

-0.58%↓

GEV.US

605.48

+0.89%↑

GE

276.29

+0.12%↑

RTX

151.9

-1.32%↓

CAT

417.84

-1.1%↓

BA

229.49

-0.58%↓

GEV.US

605.48

+0.89%↑

GE

276.29

+0.12%↑

RTX

151.9

-1.32%↓

CAT

417.84

-1.1%↓

BA

229.49

-0.58%↓

GEV.US

605.48

+0.89%↑

Exponent Inc

Затворен

СекторИндустриални

69.6 -1.9

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

69.37

Максимум

71

Ключови измерители

By Trading Economics

Приходи

-97K

27M

Продажби

-3.5M

142M

P/E

Средно за сектора

35.678

38.414

EPS

0.52

Дивидентна доходност

1.62

Марж на печалбата

18.704

Служители

958

EBITDA

-5.9M

34M

Препоръки

By TipRanks

Препоръки

Купи

12-месечна прогноза

+9.15% upside

Дивиденти

By Dow Jones

Дивидентна доходност

Средно за сектора

1.62%

2.29%

Следващи печалби

23.10.2025 г.

Следваща дата на дивидент

19.09.2025 г.

Следваща дата на екс-дивидент

5.12.2025 г.

Пазарни показатели

By TradingEconomics

Пазарна капитализация

-22M

3.6B

Предишно отваряне

71.5

Предишно затваряне

69.6

Настроения в новините

By Acuity

61%

39%

414 / 459 Класиране в Industrials

Техническа оценка

By Trading Central

Увереност

Strong Bearish Evidence

Exponent Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

9.09.2025 г., 23:37 ч. UTC

Горещи акции

Stocks to Watch: Oracle, Wearable Devices, GameStop

9.09.2025 г., 20:41 ч. UTC

Печалби

Oracle's Backlog Surges With Major Customer Deals in 1Q

9.09.2025 г., 20:30 ч. UTC

Печалби

GameStop 2Q Sales, Profit Rise

9.09.2025 г., 23:19 ч. UTC

Пазарно говорене

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9.09.2025 г., 21:35 ч. UTC

Печалби

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9.09.2025 г., 21:32 ч. UTC

Печалби

Oracle's Backlog Swells With Big Customer Deals -- Update

9.09.2025 г., 21:02 ч. UTC

Придобивния, сливания и поглъщания

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9.09.2025 г., 20:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

9.09.2025 г., 20:33 ч. UTC

Печалби

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9.09.2025 г., 20:26 ч. UTC

Печалби

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9.09.2025 г., 20:23 ч. UTC

Печалби

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9.09.2025 г., 20:12 ч. UTC

Печалби

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9.09.2025 г., 20:10 ч. UTC

Печалби

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9.09.2025 г., 20:10 ч. UTC

Печалби

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9.09.2025 г., 20:09 ч. UTC

Печалби

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9.09.2025 г., 20:09 ч. UTC

Печалби

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9.09.2025 г., 20:08 ч. UTC

Печалби

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9.09.2025 г., 20:08 ч. UTC

Печалби

Oracle 1Q Operating Income Was $4.3 B >ORCL

9.09.2025 г., 20:08 ч. UTC

Печалби

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9.09.2025 г., 20:08 ч. UTC

Печалби

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9.09.2025 г., 20:07 ч. UTC

Печалби

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9.09.2025 г., 20:06 ч. UTC

Печалби

Oracle 1Q Software Revenue $5.72B >ORCL

9.09.2025 г., 20:06 ч. UTC

Печалби

Synopsys 3Q Adj EPS $3.39 >SNPS

9.09.2025 г., 20:06 ч. UTC

Печалби

Oracle 1Q Cloud Revenue $7.19B >ORCL

9.09.2025 г., 20:05 ч. UTC

Печалби

Oracle 1Q Rev $14.93B >ORCL

9.09.2025 г., 20:05 ч. UTC

Печалби

Oracle 1Q EPS $1.01 >ORCL

9.09.2025 г., 20:05 ч. UTC

Печалби

Synopsys 3Q EPS $1.50 >SNPS

9.09.2025 г., 20:05 ч. UTC

Печалби

Oracle 1Q Services Revenue $1.35B >ORCL

9.09.2025 г., 20:05 ч. UTC

Печалби

Oracle 1Q Adj EPS $1.47 >ORCL

9.09.2025 г., 20:05 ч. UTC

Печалби

Oracle 1Q Hardware Revenue $670M >ORCL

Сравнение с други в отрасъла

Ценова промяна

Exponent Inc Прогноза

Ценова цел

By TipRanks

9.15% нагоре

12-месечна прогноза

Среден 77.5 USD  9.15%

Висок 79 USD

Нисък 76 USD

Според 4 анализатори от Wall Street, предложили 12-месечна ценова цел за Exponent Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

4 ratings

2

Купи

2

Задържане

0

Продай

Техническа оценка

By Trading Central

75.29 / 78.99Подкрепа & съпротива

Краткосрочен план

Strong Bearish Evidence

Средносрочен план

Weak Bearish Evidence

Дългосрочен план

Bearish Evidence

Настроение

By Acuity

414 / 459 Класиране в Индустриални

Настроения в новините

Мечи доказателства

Волатилност

Под средното

Обем новини (RCV)

Над средното

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

$

Относно Exponent Inc

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. The company was founded in 1967 and is headquartered in Menlo Park, California.
help-icon Live chat